15050312

Source:http://linkedlifedata.com/resource/pubmed/id/15050312

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0013216, umls-concept:C0015020, umls-concept:C0034656, umls-concept:C0205178, umls-concept:C0205187, umls-concept:C0205420, umls-concept:C0600688, umls-concept:C0684224, umls-concept:C0684249, umls-concept:C1280500, umls-concept:C1522449
pubmed:issue	5
pubmed:dateCreated	2004-3-30
pubmed:abstractText	To determine the ability of amifostine to reduce the severity and/or incidence of the acute toxicities of concurrent chemotherapy and radiotherapy (RT) for non-small-cell lung cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA16672, http://linkedlifedata.com/resource/pubmed/grant/CA6294
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amifostine, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Radiation-Protective Agents
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0360-3016
pubmed:author	pubmed-author:AllenPamela KPK, pubmed-author:BlumenscheinGeorge RGRJr, pubmed-author:BooksC ACA, pubmed-author:CoxJames DJD, pubmed-author:FossellaFrank VFV, pubmed-author:GarzaVeronica PVP, pubmed-author:GlissonBonnie SBS, pubmed-author:HerbstRoy SRS, pubmed-author:KaplanBunyaminB, pubmed-author:KiesMerrill SMS, pubmed-author:KomakiRitsukoR, pubmed-author:KurieJohnathanJ, pubmed-author:LeeHoon KHK, pubmed-author:LiaoZhongxingZ, pubmed-author:LuCharlesC, pubmed-author:MilasLukaL, pubmed-author:MooringDeidreD, pubmed-author:PapadimitrakopoulouVassiliki AVA, pubmed-author:PistersKatherine MKM, pubmed-author:StevensCraig WCW, pubmed-author:TuckerSusan LSL, pubmed-author:ZinnerRalph GRG
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	58
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1369-77
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15050312-Adult, pubmed-meshheading:15050312-Aged, pubmed-meshheading:15050312-Aged, 80 and over, pubmed-meshheading:15050312-Agranulocytosis, pubmed-meshheading:15050312-Amifostine, pubmed-meshheading:15050312-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15050312-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:15050312-Cisplatin, pubmed-meshheading:15050312-Combined Modality Therapy, pubmed-meshheading:15050312-Confidence Intervals, pubmed-meshheading:15050312-Etoposide, pubmed-meshheading:15050312-Female, pubmed-meshheading:15050312-Follow-Up Studies, pubmed-meshheading:15050312-Humans, pubmed-meshheading:15050312-Lung Neoplasms, pubmed-meshheading:15050312-Male, pubmed-meshheading:15050312-Middle Aged, pubmed-meshheading:15050312-Radiation Pneumonitis, pubmed-meshheading:15050312-Radiation-Protective Agents, pubmed-meshheading:15050312-Radiotherapy Dosage, pubmed-meshheading:15050312-Survival Analysis, pubmed-meshheading:15050312-Treatment Outcome
pubmed:year	2004
pubmed:articleTitle	Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
pubmed:affiliation	Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. rkomaki@mdanderson.org
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't